Skip to main content

Advertisement

Log in

Disparities in DCIS

  • Published:
Current Breast Cancer Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Although the impact of socioeconomic and racial/ethnic disparities in the pathogenesis and outcomes of invasive breast cancer has been well defined, data regarding DCIS are sparse. The purpose of this review is to address the influence of disparities in the pathogenesis and prognosis of DCIS and examine the factors that are associated with adverse outcomes in underserved and minority populations.

Recent Findings

Racial/ethnic disparities in DCIS are evident in all aspects of cancer care continuum, from prevention to development of invasive cancer. Increased prevalence of preventable risk factors and disproportionate screening are evident in socioeconomically disadvantaged populations. Furthermore, unequal access to different treatment modalities as well as unfavorable hormonal receptor profiling in certain racial/ethnic groups may be associated with worse morbidity and higher incidence of subsequent breast cancer events.

Summary

Failure to understand socioeconomic disparities can affect the quality of care of patients with DCIS and subsequently invasive breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data Availability

Data is available for use in the public domain as permitted by Journal practices.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Tan PH, Ellis I, Allison K, et al. The 2019 World Health Organization classification of tumours of the breast. Histopathology. 2020;77(2):181–5. https://doi.org/10.1111/his.14091.

    Article  PubMed  Google Scholar 

  2. Cowell CF, Weigelt B, Sakr RA, et al. Progression from ductal carcinoma in situ to invasive breast cancer: revisited. Mol Oncol. 2013;7(5):859–69. https://doi.org/10.1016/j.molonc.2013.07.005.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Newman LA, Bensenhaver JM, Ductal carcinoma in situ and microinvasive/borderline breast cancer, Springer, 2015.

  4. •• Kalwaniya DS, Gairola M, Gupta S, Pawan G. Ductal carcinoma in situ: a detailed review of current practices. Cureus. 2023;15(4):e37932. https://doi.org/10.7759/cureus.37932. ()

    Article  PubMed  PubMed Central  Google Scholar 

  5. Horner M, Ries L, Krapcho M, et al, SEER Cancer Statistics Review, 1975–2006, National Cancer Institute; 2009. http://seer.cancer.gov/csr/1975_2006, accessed August 30, 2010.

  6. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA. 1996;275(12):913–8.

    Article  CAS  PubMed  Google Scholar 

  7. Kerlikowske K. Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010;2010(41):139–41. https://doi.org/10.1093/jncimonographs/lgq027.

    Article  PubMed  PubMed Central  Google Scholar 

  8. van Seijen M, Lips EH, Thompson AM, et al. Ductal carcinoma in situ: to treat or not to treat, that is the question. Br J Cancer. 2019;121(4):285–92. https://doi.org/10.1038/s41416-019-0478-6.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Vatovec C, Erten MZ, Kolodinsky J, et al. Ductal carcinoma in situ: a brief review of treatment variation and impacts on patients and society. Crit Rev Eukaryot Gene Expr. 2014;24(4):281–6. https://doi.org/10.1615/critreveukaryotgeneexpr.2014011495.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Doke K, Butler S, Mitchell MP. Current therapeutic approaches to DCIS. J Mammary Gland Biol Neoplasia. 2018;23(4):279–91. https://doi.org/10.1007/s10911-018-9415-1.

    Article  PubMed  Google Scholar 

  11. Bailes AA, Kuerer HM, Lari SA, Jones LA, Brewster AM. Impact of race and ethnicity on features and outcome of ductal carcinoma in situ of the breast. Cancer. 2013;119(1):150–7. https://doi.org/10.1002/cncr.27707.

    Article  PubMed  Google Scholar 

  12. Pocock B, Nash S, Klein L, El-Tamer M, Schnabel FR, Joseph KA. Disparities in time to definitive surgical treatment between black and white women diagnosed with ductal carcinoma in situ. Am J Surg. 2007;194(4):521–3. https://doi.org/10.1016/j.amjsurg.2007.06.015.

    Article  PubMed  Google Scholar 

  13. Kaplan CP, Nápoles AM, Hwang ES, et al. Selection of treatment among Latina and non-Latina white women with ductal carcinoma in situ. J Womens Health. 2011;20(2):215–23. https://doi.org/10.1089/jwh.2010.1986.

    Article  Google Scholar 

  14. Colditz GA, Bohlke K. Priorities for the primary prevention of breast cancer. CA Cancer J Clin. 2014;64(3):186–94. https://doi.org/10.3322/caac.21225.

    Article  PubMed  Google Scholar 

  15. Sprague BL, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Hampton JM, Newcomb PA. Proportion of invasive breast cancer attributable to risk factors modifiable after menopause. Am J Epidemiol. 2008;168(4):404–11. https://doi.org/10.1093/aje/kwn143.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Sauter ER. Breast cancer prevention: current approaches and future directions. Eur J Breast Health. 2018;14(2):64–71. https://doi.org/10.5152/ejbh.2018.3978.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Lin SC, Gathua N, Thompson C, Sripipatana A, Makaroff L. Disparities in smoking prevalence and associations with mental health and substance use disorders in underserved communities across the United States. Cancer. 2022;128(9):1826–31. https://doi.org/10.1002/cncr.34132.

    Article  PubMed  Google Scholar 

  18. Cornelius ME, Loretan CG, Wang TW, Jamal A, Homa DM. Tobacco product use among adults - United States, 2020 MMWR. Morbidity Mortal Week Rep. 2022;71(11):397–405. https://doi.org/10.15585/mmwr.mm7111a1.

    Article  Google Scholar 

  19. Okobi OE, Ajayi OO, Okobi TJ, et al. The burden of obesity in the rural adult population of America. Cureus. 2021;13(6):e15770. https://doi.org/10.7759/cureus.15770.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Befort CA, Nazir N, Perri MG. Prevalence of obesity among adults from rural and urban areas of the United States: findings from NHANES (2005–2008). J Rural Health. 2012;28(4):392–7. https://doi.org/10.1111/j.1748-0361.2012.00411.x.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Flanagan MR, Tang MC, Baglia ML, Porter PL, Malone KE, Li CI. Relationship between anthropometric factors and risk of second breast cancer among women with a history of ductal carcinoma in situ. JNCI Cancer Spectr. 2018;2(2):pky020. https://doi.org/10.1093/jncics/pky020.

    Article  PubMed  PubMed Central  Google Scholar 

  22. •• Almekinders MMM, Schaapveld M, Thijssen B, et al. Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ. NPJ Breast Cancer. 2021;7(1):31. https://doi.org/10.1038/s41523-021-00232-w. (This case-control study assesses breast adipose features with the risk of developing ipsilateral breast cancer after DCIS.)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. •• Ganguly AP, Baker KK, Redman MW, McClintock AH, Yung RL. Racial disparities in the screening mammography continuum within a heterogeneous health care system. Cancer. 2023;129(S19):3171–81. https://doi.org/10.1002/cncr.34632. (The authors describe the racial disparities in mammographic screening referrals between non-Hispanic White and Black patients.)

    Article  PubMed  Google Scholar 

  24. Ahmed AT, Welch BT, Brinjikji W, et al. Racial disparities in screening mammography in the United States: a systematic review and meta-analysis. J Am Coll Radiol. 2017;14(2):157-165.e9. https://doi.org/10.1016/j.jacr.2016.07.034.

    Article  PubMed  Google Scholar 

  25. Pocock B, Nash S, Klein L, El-Tamer M, Schnabel FR, Joseph KA. Disparities in time to definitive surgical treatment between black and white women diagnosed with ductal carcinoma in situ. Am J Surg. 2007;194(4):521–3. https://doi.org/10.1016/j.amjsurg.2007.06.015.

    Article  PubMed  Google Scholar 

  26. Peek ME, Han JH. Disparities in screening mammography. Current status, interventions and implications. J Gen Intern Med. 2004;19(2):184–94. https://doi.org/10.1111/j.1525-1497.2004.30254.x.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Brawarsky P, Neville BA, Fitzmaurice GM, Hassett MJ, Haas JS. Use of annual mammography among older women with ductal carcinoma in situ. J Gen Intern Med. 2012;27(5):500–5. https://doi.org/10.1007/s11606-011-1918-z.

    Article  PubMed  Google Scholar 

  28. Byng D, Thomas SM, Rushing CN, et al. Surveillance imaging after primary diagnosis of ductal carcinoma in situ. Radiology. 2023;307(1):e221210. https://doi.org/10.1148/radiol.221210.

    Article  PubMed  Google Scholar 

  29. Skinner CS, Strecher VJ, Hospers H. Physicians’ recommendations for mammography: do tailored messages make a difference? Am J Public Health. 1994;84(1):43–9. https://doi.org/10.2105/ajph.84.1.43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Zavertnik JJ, McCoy CB, Robinson DS, Love N. Cost-effective management of breast cancer. Cancer. 1992;69(7 Suppl):1979–84. https://doi.org/10.1002/1097-0142(19920401)69:7+%3c1979::AID-CNCR2820691719%3e3.0.CO;2-C.

    Article  CAS  PubMed  Google Scholar 

  31. Flynn BS, Gavin P, Worden JK, Ashikaga T, Gautam S, Carpenter J. Community education programs to promote mammography participation in rural New York State. Prev Med. 1997;26(1):102–8. https://doi.org/10.1006/pmed.1997.0110.

    Article  CAS  PubMed  Google Scholar 

  32. May DS, Lee NC, Nadel MR, Henson RM, Miller DS. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women. AJR Am J Roentgenol. 1998;170(1):97–104.

    Article  CAS  PubMed  Google Scholar 

  33. Gardner MP, Adams A, Jeffreys M. Interventions to increase the uptake of mammography amongst low income women: a systematic review and meta-analysis. PLoS One. 2013;8(2):e55574. https://doi.org/10.1371/journal.pone.0055574.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  34. Legler J, Meissner HI, Coyne C, Breen N, Chollette V, Rimer BK. The effectiveness of interventions to promote mammography among women with historically lower rates of screening. Cancer Epidemiol Biomarkers Prev. 2002;11(1):59–71.

    PubMed  Google Scholar 

  35. Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102(3):170–8. https://doi.org/10.1093/jnci/djp482.

    Article  PubMed  Google Scholar 

  36. Innos K, Horn-Ross PL. Recent trends and racial/ethnic differences in the incidence and treatment of ductal carcinoma in situ of the breast in California women. Cancer. 2003;97(4):1099–106. https://doi.org/10.1002/cncr.11104.

    Article  PubMed  Google Scholar 

  37. Ryser MD, Hendrix LH, Worni M, Liu Y, Hyslop T, Hwang ES. Incidence of ductal carcinoma in situ in the United States, 2000–2014. Cancer Epidemiol Biomarkers Prev. 2019;28(8):1316–23. https://doi.org/10.1158/1055-9965.EPI-18-1262.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Newman LA. Breast cancer in African-American women. Oncologist. 2005;10(1):1–14. https://doi.org/10.1634/theoncologist.10-1-1.

    Article  MathSciNet  PubMed  Google Scholar 

  39. Amirikia KC, Mills P, Bush J, Newman LA. Higher population-based incidence rates of triple-negative breast cancer among young African-American women: implications for breast cancer screening recommendations. Cancer. 2011;117(12):2747–53. https://doi.org/10.1002/cncr.25862.

    Article  PubMed  Google Scholar 

  40. Bailes AA, Kuerer HM, Lari SA, Jones LA, Brewster AM. Impact of race and ethnicity on features and outcome of ductal carcinoma in situ of the breast. Cancer. 2013;119(1):150–7. https://doi.org/10.1002/cncr.27707.

    Article  PubMed  Google Scholar 

  41. Nelson C, Bai H, Neboori H, et al. Multi-institutional experience of ductal carcinoma in situ in black vs white patients treated with breast-conserving surgery and whole breast radiation therapy. Int J Radiat Oncol Biol Phys. 2012;84(3):e279–83. https://doi.org/10.1016/j.ijrobp.2012.03.068.

    Article  PubMed  Google Scholar 

  42. Liu Y, West R, Weber JD, Colditz GA. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ. Cancer. 2019;125(18):3225–33. https://doi.org/10.1002/cncr.32200.

    Article  CAS  PubMed  Google Scholar 

  43. Dreyer MS, Nattinger AB, McGinley EL, Pezzin LE. Socioeconomic status and breast cancer treatment. Breast Cancer Res Treat. 2018;167(1):1–8. https://doi.org/10.1007/s10549-017-4490-3.

    Article  PubMed  Google Scholar 

  44. Moubadder L, Collin LJ, Nash R, et al. Drivers of racial, regional, and socioeconomic disparities in late-stage breast cancer mortality. Cancer. 2022;128(18):3370–82. https://doi.org/10.1002/cncr.34391.

    Article  PubMed  Google Scholar 

  45. Zhang S, Liu Y, Yun S, Lian M, Komaie G, Colditz GA. Impacts of neighborhood characteristics on treatment and outcomes in women with ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev. 2018;27(11):1298–306. https://doi.org/10.1158/1055-9965.EPI-17-1102.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Madubata CC, Liu Y, Goodman MS, et al. Comparing treatment and outcomes of ductal carcinoma in situ among women in Missouri by race. Breast Cancer Res Treat. 2016;160(3):563–72. https://doi.org/10.1007/s10549-016-4030-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Haque R, Achacoso NS, Fletcher SW, et al. Treatment of ductal carcinoma in situ among patients cared for in large integrated health plans. Am J Manag Care. 2010;16(5):351–60.

    PubMed  PubMed Central  Google Scholar 

  48. Kruper L, Xu X, Henderson K, Bernstein L. Disparities in reconstruction rates after mastectomy for ductal carcinoma in situ (DCIS): patterns of care and factors associated with the use of breast reconstruction for DCIS compared with invasive cancer. Ann Surg Oncol. 2011;18(11):3210–9. https://doi.org/10.1245/s10434-011-2010-y.

    Article  PubMed  Google Scholar 

  49. Kaplan CP, Nápoles AM, Hwang ES, et al. Selection of treatment among Latina and non-Latina white women with ductal carcinoma in situ. J Womens Health. 2011;20(2):215–23. https://doi.org/10.1089/jwh.2010.1986.

    Article  Google Scholar 

  50. López ME, Kaplan CP, Nápoles AM, Hwang ES, Livaudais JC, Karliner LS. Satisfaction with treatment decision-making and treatment regret among Latinas and non-Latina whites with DCIS. Patient Educ Couns. 2014;94(1):83–9. https://doi.org/10.1016/j.pec.2013.09.005.

    Article  PubMed  Google Scholar 

  51. Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P. Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol. 2015;1(7):888–96. https://doi.org/10.1001/jamaoncol.2015.2510.

    Article  PubMed  Google Scholar 

  52. Pawloski KR, Tadros AB, Sevilimedu V, et al. Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy. Breast Cancer Res Treat. 2021;186(3):617–24. https://doi.org/10.1007/s10549-021-06129-3.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Li CI, Malone KE, Saltzman BS, Daling JR. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988–2001. Cancer. 2006;106(10):2104–12. https://doi.org/10.1002/cncr.21864.

    Article  PubMed  Google Scholar 

  54. Joslyn SA. Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival. Breast J. 2006;12(1):20–7. https://doi.org/10.1111/j.1075-122X.2006.00182.x.

    Article  PubMed  Google Scholar 

  55. Taparra K, Fukui J, Killeen J, Sumida K, Loo LWM, Hernandez BY. Racial and ethnic disparities in rates of invasive second breast cancer among women with ductal carcinoma in situ in Hawai’i. JAMA Netw Open. 2021;4(10):e2128977. https://doi.org/10.1001/jamanetworkopen.2021.28977.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

G.S, C.E and J.J wrote the main manuscript text. A.S prepared table 1. Critical revision and final approval of the article: L.N. All authors reviewed the manuscript.

Corresponding author

Correspondence to Georgia Syrnioti.

Ethics declarations

Competing interests

The authors declare no competing interests.

Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Syrnioti, G., Johnson, J., Eden, C.M. et al. Disparities in DCIS. Curr Breast Cancer Rep 16, 69–75 (2024). https://doi.org/10.1007/s12609-024-00523-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12609-024-00523-8

Keywords

Navigation